HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment.
Michela E BurloneMattia BellanMatteo N BarbagliaGinevra MocchettiVenkata R MallelaRosalba MinisiniCristina RigamontiMario PirisiPublished in: Clinical journal of gastroenterology (2022)
Our findings confirm that genes modulating liver fat and lipogenesis are important risk factors for HCC development among cirrhotics C treated with DAA.